Patient-specific treatment of Polycythemia vera using a model of erythropoiesis

Patient-specific treatment of Polycythemia vera using a model of erythropoiesis - MODEST-PV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011060

Enrollment

Registered

2017-06-02

Start date

2017-10-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D45

Interventions

Group 1: Appointments for bloodletting following standard procedure, based on lab values (data taken from retrospective medical records). Group 2: Appointments for bloodletting using the model, which

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: PV patient

Exclusion criteria

Exclusion criteria: Chemotherapy

Design outcomes

Primary

Measure	Time frame
Quality of model predictions w.r.t. normal indication for bloodletting (only blood count)	—

Secondary

Measure	Time frame
Precision of prognosed hematocrit (model response compared to blood count)	—

Countries

Germany

Contacts

Public ContactManuel Tetschke

Institut für Mathematische OptimierungFakultät für MathematikOtto-von-Guericke Universität Magdeburg

tetschke@ovgu.de+49-391-67 51449

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026